Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report

被引：3

作者：

Sunagawa, Shawnalyn W. ^{[1
,3
]}

Havens, Joshua P. ^{[1
,2
]}

Podany, Anthony ^{[1
]}

Walker, Bryan ^{[2
]}

Scarsi, Kimberly K. ^{[1
,2
]}

Bares, Sara H. ^{[2
]}

机构：

[1] Univ Nebraska Med Ctr, Coll Pharm, Omaha, NE 68198 USA

[2] Univ Nebraska Med Ctr, Coll Med, Dept Internal Med, Div Infect Dis, Omaha, NE 68198 USA

[3] Univ Nebraska Med Ctr, Dept Pharm Practice & Sci, 986145 Nebraska Med Ctr, Omaha, NE 68198 USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2023年 / 10卷 / 12期

关键词：

drug-drug interactions; long-acting cabotegravir/rilpivirine; plasma concentrations; rifamycins;

D O I：

10.1093/ofid/ofad604

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

As antiretroviral therapy advancements focus on long-acting medications, there is a need to assess the potential impact of drug-drug interactions. We present a real-world case of long-acting cabotegravir/rilpivirine co-administered with intravenous rifampin. The combination resulted in both cabotegravir and rilpivirine concentrations falling below 4 times the protein-adjusted IC90.

引用

页数：3

共 50 条

[1] Implementing long-acting injectable cabotegravir and rilpivirine in Africa
Orkin, Chloe
Ring, Kyle
LANCET INFECTIOUS DISEASES, 2024, 24 (10): : 1060 - 1061
[2] Characterization of a case of virological failure after switch to long-acting cabotegravir and rilpivirine
Mazzitelli, Maria
Avolio, Antonio
Carandina, Riccardo
Parisi, Saverio
Wensing, Annemarie
Cattelan, Annamaria
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 2074 - 2076
[3] Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV
van der Wekken-Pas, Lena
Weiss, Fabian
Simon-Zuber, Charlotte
Sebisch, Rena
Wiese, Carmen
van Leeuwen, Elisabeth
Burger, David
Colbers, Angela
CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1468 - 1471
[4] Effectiveness of long-acting ART with cabotegravir/rilpivirine in the ICONA cohort
Gagliardini, Roberta
De Benedittis, Sara
Tavelli, Alessandro
Lapadula, Giuseppe
Mazzotta, Valentina
Bruzzesi, Elena
Cervo, Adriana
Carrozzo, Giorgia
Sarracino, Annalisa
Rusconi, Stefano
Marchetti, Giulia
Ceccherini-Silberstein, Francesca
Antinori, Andrea
Monforte, Antonella d'Arminio
Muccini, Camilla
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 89 - 90
[5] Experiences to date with the logistical management of long-acting cabotegravir and rilpivirine
Johnson, Kamile
Sawkin, Mark T.
DRUGS IN CONTEXT, 2022, 11
[6] Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine
Ripamonti, Diego
Borghetti, Alberto
Zazzi, Maurizio
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (10) : 2720 - 2724
[7] Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities
Llibre, Josep M.
Kuritzkes, Daniel A. R.
CLINICAL INFECTIOUS DISEASES, 2023, 76 (09) : 1655 - 1657
[8] A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine
Valin, Nadia
Lambert-Niclot, Sidonie
Torres, Emma
Meynard, Jean Luc
Perillaud-Dubois, Claire
Morand-Joubert, Laurence
Lacombe, Karine
CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 196 - 197
[9] Expanded Insights From a Case Study on Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnancy
Ziemba, Lauren
Ketchum, Rachel
Brummel, Sean
CLINICAL INFECTIOUS DISEASES, 2025,
[10] Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice
Borghetti, Alberto
Farinacci, Damiano
Ciccullo, Arturo
Dusina, Alex
Moschese, Davide
Iannone, Valentina
D'Angelillo, Anna
Lombardi, Francesca
Delle Donne, Valentina
Massaroni, Valentina
Visconti, Elena
Tamburrini, Enrica
Di Giambenedetto, Simona
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4970 - 4974

← 1 2 3 4 5 →